ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028

Lifesciences | Pharmaceuticals

ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028

Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s research report, the veterinary vaccines market in the Asia-Pacific is estimated to grow with a CAGR of 8.79% over the forecasting period 2022-2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this region include:

•         China

•         India

•         Japan

•         South Korea

•         ASEAN Countries

•         Australia & New Zealand

•         Rest of Asia-Pacific

Asia accounts for the highest population of livestock, such as pigs, cattle, fish, and poultry, which makes it an attractive market, having plenty of opportunities for veterinary vaccine manufacturers. Also, the enhanced focus in this region by domestic as well as international market players in terms of investments, R&D facilities, manufacturing facilities, and so on, acts as driving factors for the APAC’s veterinary vaccine market.

In Malaysia, the concept of pet humanization has increased dramatically in the past few years. There is a high rate of adoption of cats and dogs across the country. Several pet care organizations around the nation are also working on various programs to promote pet adoption. For example, Voice For Paws conducts adoption drives in the capital city of Kuala Lumpur. Thus, the vast pet population and their high adoption rate are expected to promote the veterinary vaccines market growth in the ASEAN country.

Meanwhile, the Rest of Asia-Pacific region consists of countries that are agricultural economies, where farm animals such as dairy cows, beef cattle, goats, sheep, etc., are used for different purposes such as to obtain dairy or meat products. Any deterioration in the animals’ health due to disease can cost these economies heavily. The high reliance on livestock for food production makes it important to take care of them. This presents an opportunity to the players in the veterinary vaccines market in Rest of Asia-Pacific to capitalize on.

Cattle are used for multiple purposes, ranging from farming to consumption. They play a vital role in terms of food consumption in the form of dairy and meat products. As they live in a group or herd, cattle are prone to diseases. Therefore, there is a chance of the disease spreading from one animal to the other, and, thereby, to the whole herd. Vaccination is a must to avoid this problem. The most commonly found cattle diseases are black quarter disease, anthrax disease, rinderpest, foot-and-mouth disease, etc. The studied report assesses the market’s growth based on animal type, disease type, and product type. Here, the animal type segment comprises livestock animals, companion animals, and aquaculture. The livestock animals sub-segment includes cattle, poultry, pigs, sheep, and other livestock animals.

Leading companies considered in the veterinary vaccines market include Indian Immunologicals Limited, Merck Animal Health, Zoetis Inc, Hester Biosciences Ltd, Brilliant Bio Pharma, and Phibro Animal Health.

Hester Biosciences Ltd is a renowned animal health company. It operates in verticals like animal vaccines, poultry vaccines, animal health products, and poultry health products. Additionally, Hester also offers services such as diagnostic labs & seroprofiling kits for poultry flocks and mastitis control programs for cattle. The India-based company was founded in 1987 and is headquartered in Ahmedabad, Gujarat. Hester is the first company in the country to manufacture goat pox vaccine and also its second-largest poultry vaccine manufacturer. It enjoys economies of scale owing to its massive production capacity.

 

 

Key deliverables of the report:

·       Market CAGR during the forecasting years 2022-2028

·       Detailed data highlighting key insights, industry components, and market strategies

·       Comprehensive information and estimation of the veterinary vaccines market revenue growth in Asia-Pacific and its influence on the parent market

·       In-depth study of forthcoming trends in consumer behavioral patterns

·       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

·       A wide-ranging study of factors that will challenge the APAC veterinary vaccines market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC VETERINARY VACCINES MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE VETERINARY VACCINES MARKET

2.2. KEY INSIGHTS

2.2.1. INCREASING INNOVATION BY MARKET PARTICIPANTS

2.2.2. ADVANCEMENTS IN VACCINE AND DIAGNOSTIC TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VALUE CHAIN ANALYSIS

2.6. KEY BUYING CRITERIA

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY MARKET STRATEGIES

2.9.1. MERGERS & ACQUISITIONS

2.9.2. CONTRACTS & AGREEMENTS

2.9.3. PRODUCT LAUNCHES

2.9.4. EXPANSIONS & DIVESTITURES

2.10. MARKET DRIVERS

2.10.1. HIGH VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES

2.10.2. GOVERNMENT-ORGANIZED VACCINATION DRIVES      

2.10.3. ADVANCED VACCINE RESEARCH AND DEVELOPMENT

2.11. MARKET CHALLENGES

2.11.1. LACK OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS

2.11.2. STRINGENT RULES AND REGULATIONS PERTAINING TO VACCINE USE

2.12. MARKET OPPORTUNITIES

2.12.1. EXPANSION OF THE ANIMAL HEALTHCARE MARKET IN THE ASIA-PACIFIC

2.12.2. RISING DEMAND FOR COMPANION ANIMALS

3. ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE

3.1. LIVESTOCK ANIMALS

3.1.1. CATTLE

3.1.2. PIGS

3.1.3. POULTRY

3.1.4. SHEEP

3.1.5. OTHER LIVESTOCK ANIMALS

3.2. COMPANION ANIMALS

3.2.1. CANINE

3.2.2. FELINE

3.2.3. EQUINE

3.3. AQUACULTURE

4. ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE

4.1. CANINE DISEASE

4.2. PORCINE DISEASE

4.3. BOVINE DISEASE

4.4. POULTRY DISEASE

4.5. AQUACULTURE DISEASE

4.6. OTHER DISEASE TYPE

5. ASIA-PACIFIC VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE

5.1. ATTENUATED VACCINES

5.2. INACTIVATED VACCINES

5.3. TOXOID VACCINES

5.4. CONJUGATE VACCINES

5.5. DNA VACCINES

5.6. RECOMBINANT VACCINES

5.7. SUBUNIT VACCINES

6. ASIA-PACIFIC VETERINARY VACCINES MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH

7.2. BRILLIANT BIO PHARMA

7.3. CEVA SANTE ANIMALE

7.4. ELANCO ANIMAL HEALTH INC

7.5. HESTER BIOSCIENCES LTD

7.6. HIPRA

7.7. INDIAN IMMUNOLOGICALS LIMITED

7.8. MERCK ANIMAL HEALTH

7.9. PHIBRO ANIMAL HEALTH

7.10. VAXXINOVA GMBH

7.11. VIRBAC SA

7.12. ZOETIS INC

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: VENDOR SCORECARD

TABLE 4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: VALUE CHAIN ANALYSIS

FIGURE 3: KEY BUYING CRITERIA

FIGURE 4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)

FIGURE 7: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)

FIGURE 14: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)

FIGURE 19: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 26: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 30: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 31: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 32: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 33: ASIA-PACIFIC VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 34: CHINA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: JAPAN VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: INDIA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 37: SOUTH KOREA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 38: ASEAN COUNTRIES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 39: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 40: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying